SPDR S&P Pharmaceuticals ETF (XPH) Dividend Yield, Date & History $44.66 +0.32 (+0.72%) (As of 12/17/2024 ET) Add Compare Share Share Dividend Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Dividend SummaryDividend Yield1.50%Annual Dividend$0.67Recent Dividend Payment Jun. 26 SPDR S&P Pharmaceuticals ETF (XPH) pays an annual dividend of $0.67 per share, with a dividend yield of 1.50%. The next payment of $0.1557 per share was paid on Wednesday, June 26, to investors who owned the stock before the ex-dividend date of Monday, June 24. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryXPH Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of SPDR S&P Pharmaceuticals ETF's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open SPDR S&P Pharmaceuticals ETF in Dividend Calculator XPH Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks SPDR S&P Pharmaceuticals ETF's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open SPDR S&P Pharmaceuticals ETF in Dividend Yield Calculator Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now SPDR S&P Pharmaceuticals ETF vs. The CompetitionCompare SPDR S&P Pharmaceuticals ETF's annual dividend, yield, and 3-year growth rate with averages for and NYSEARCA companies to evaluate its performance against the market.TypeSPDR S&P Pharmaceuticals ETF CompaniesNYSEARCA CompaniesAnnual Dividend$0.67$0.01$1.06Dividend Yield1.50%15.22%17.03% SPDR S&P Pharmaceuticals ETF Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date1/2/2024$0.1557+$0.0847119.19%6/24/20246/24/20246/26/2024This table shows SPDR S&P Pharmaceuticals ETF's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. SPDR S&P Pharmaceuticals ETF Dividend - Frequently Asked Questions What is SPDR S&P Pharmaceuticals ETF's dividend yield? The current dividend yield for SPDR S&P Pharmaceuticals ETF is 1.50%. Learn more on XPH's dividend yield history. How much is SPDR S&P Pharmaceuticals ETF's annual dividend? The annual dividend for XPH shares is $0.67. Learn more on XPH's annual dividend history. When was SPDR S&P Pharmaceuticals ETF's most recent dividend payment? SPDR S&P Pharmaceuticals ETF's most recent dividend payment of $0.1557 per share was made to shareholders on Wednesday, June 26, 2024. When was SPDR S&P Pharmaceuticals ETF's most recent ex-dividend date? SPDR S&P Pharmaceuticals ETF's most recent ex-dividend date was Monday, June 24, 2024. When did SPDR S&P Pharmaceuticals ETF last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.0847 on Tuesday, January 2, 2024. More Dividend Resources from MarketBeat Related Companies Simplify Health Care ETF Dividend Direxion Daily Healthcare Bull 3x Shares Dividend Invesco Dorsey Wright Healthcare Momentum ETF Dividend Invesco S&P SmallCap Health Care ETF Dividend ProShares Ultra Health Care Dividend Simplify Propel Opportunities ETF Dividend SPDR S&P Health Care Services ETF Dividend ProShares Ultra Nasdaq Biotechnology Dividend Direxion Daily S&P Biotech Bear 3x Shares Dividend Invesco Biotechnology & Genome ETF Dividend Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Latest Articles Medtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond3 Best Dividend Stocks to Buy as Interest Rates FallIntuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy3 High-Yield Dividend Stocks for Income Now and Growth LaterDividend King ABM Industries is on Track for New HighsWhy Altria Stock is Still a Good Dividend PlayGet Paid While You Wait - OneMain's Juicy DividendsAlphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead More Dividend News How to piss off your liberal friends… and profit from it (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now This page (NYSEARCA:XPH) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.